Factors associated with adults' perceived need to vaccinate against hepatitis B in rural China

References

• Liu J, Fan DM. Hepatitis B in China. Lancet 2007; 369:1582-3; PMID:17499584; http://dx.doi.org/10.1016/S0140-6736(07)60723-5
   PubMed Web of Science ®Google Scholar
• Liang TJ. Hepatitis B: the virus and disease. Hepatology 2009; 49: S13-21; PMID:19399811; http://dx.doi.org/10.1002/hep.22881
   PubMed Web of Science ®Google Scholar
• Zhang CY, Zhong YS, Guo LP. Strategies to prevent hepatitis B virus infection in China: immunization, screening, and standard medical practices. Bioscience Trends 2013; 7: 7-12; PMID:23524888
   PubMed Web of Science ®Google Scholar
• Hu M, Chen W. Assessment of total economic burden of chronic hepatitis B (CHB)-related diseases in Beijing and Guangzhou, China. Value in Health 2009; 12: S89-92; PMID:20586991; http://dx.doi.org/10.1111/j.1524-4733.2009.00636.x
   PubMed Web of Science ®Google Scholar
• Lu JJ, Xu AQ, Wang J, Zhang L, Song LZ, Li RP, Zhang SX, Zhuang GH, Lu MS. Direct economic burden of hepatitis B virus related diseases: evidence from Shandong, China. BMC Health Serv Res 2013; 13:37; PMID:23368750; http://dx.doi.org/10.1186/1472-6963-13-37
   PubMed Web of Science ®Google Scholar
• Zhang H, Chao JQ, Zhu LG, Song L, Li XY, Liu P. Direct economic burden and influencing factors in patients with hepatitis B virus related diseases in Jiangsu, China. Asia Pac J Public Health 2015; 27:41S-8S; PMID:25416293; http://dx.doi.org/10.1177/1010539514560057
   PubMedGoogle Scholar
• Siddiqui M, Salmon DA, Omer SB. Epidemiology of vaccine hesitancy in the United States. Hum Vaccin Immunother 2014; 9:2643-8; http://dx.doi.org/10.4161/hv.27243
   Web of Science ®Google Scholar
• Wu Q, Zhuang GH, Wang XL, Hou TJ, Shah DP, Wei XL, Wang LR, Zhang M. Comparison of long-term immunogenicity (23 y) of 10 mu g and 20 mu g doses ofhepatitisBvaccinein healthy children. Hum Vaccin Immunother 2012; 8:1071-6; PMID:22854666; http://dx.doi.org/10.4161/hv.20656
   PubMed Web of Science ®Google Scholar
• Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine 2008; 26:6266-73; PMID:18848855; http://dx.doi.org/10.1016/j.vaccine.2008.09.056
   PubMed Web of Science ®Google Scholar
• Boccalini S, Taddei C, Ceccherini V, Bechini A, Levi M, Bartolozzi D, Bonanni P. Economic analysis of the first 20 years of universal hepatitis B vaccination program in Italy: an aposteriori evaluation and forecast of future benefits. Hum Vaccin Immunother 2013; 9:1119-28; PMID:23376840; http://dx.doi.org/10.4161/hv.23827
   PubMed Web of Science ®Google Scholar
• Yu L, Wang J, Zhu D, Leng A, Wangen KR. Hepatitis B-related knowledge and vaccination in association with discrimination against hepatitis B in rural China. Hum Vaccin Immunother, in press, DOI: 10.1080/21645515.2015.1069932
   Web of Science ®Google Scholar
• Hadler SC, Cui FQ, Averhoff F, Taylor T, Wang FZ, Li L, Liang XF, Yang WZ. The impact of hepatitis B vaccine in China and in the China GAVI Project. Vaccine 2013; 31:J66-J72; PMID:24331023; http://dx.doi.org/10.1016/j.vaccine.2013.03.043
   PubMed Web of Science ®Google Scholar
• Han CZ, Ma JC, Qi SX, Tian C. Comparison on HBV carrying status and hepatitis B vaccine inoculation rate among children at the age of 1 to 14 years between urban areas and rural areas in Hebei province. Mod Prev Med 2008; 35:2344-9.
   Google Scholar
• Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, et al. Epidemiological serosurvey of Hepatitis B in China—Declining HBV prevalence due to Hepatitis B vaccination. Vaccine 2009; 27: 6550-7; PMID:19729084; http://dx.doi.org/10.1016/j.vaccine.2009.08.048
   PubMed Web of Science ®Google Scholar
• Zhu DW, Wang J, Wangen KR. Hepatitis B vaccination coverage rates among adults in rural China: Are economic barriers relevant? Vaccine 2013; 32: 6705-10; PMID:23845801; http://dx.doi.org/10.1016/j.vaccine.2013.06.095
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang W, Wu J, Han LL, Lin CY, Gao P, Xing YL, He X, Pang XH, Li H. Hepatitis B vaccination rate in adults of Beijing: a cross-sectional study. Chinese Journal of Public Health 2010; 26: 612-4 [in Chinese].
   Google Scholar
• Zheng H, Wang FZ, Zhang GM, Cui FQ, Wu ZH, Miao N, Sun XJ, Liang XF, Li L. An economic analysis of adult hepatitis B vaccination in China. Vaccine; in press; http://dx.doi.org/10.1016/j.vaccine.2015.09.011
   Web of Science ®Google Scholar
• Zhang W, Niu JP, Li ZQ, Wang ZY. Investigation on coverage of hepatitis B vaccine and influencing factor in the population aged 15–59 years in Lanzhou city. Chinese Journal of Vaccines and Immunization 2011; 17:216-9 [in Chinese].
   Google Scholar
• Wang Z, Zhao K, Wang Y, Lv JJ, Zhang GJ, Guo N, Wang J. Analysis of the equity and its decomposition of adults taking hepatitis B vaccine in Chinese rural areas. Chinese Health Econ 2012; 31:50-2 [in Chinese]; http://dx.doi.org/10.1016/j.jhealeco.2012.01.001
   PubMed Web of Science ®Google Scholar
• Park B, Choi KS, Lee HY, Jun JK, Park EC. Socioeconomic inequalities in completion of hepatitis B vaccine series among Korean women: results from a nationwide interview survey. Vaccine 2012; 30: 5844-8; PMID:22828587; http://dx.doi.org/10.1016/j.vaccine.2012.07.022
   PubMed Web of Science ®Google Scholar
• Haber PS, Day CA, Topp L, Shanahan M, Wand H, van Beek I, Maher L. Hepatitis B vaccinationfor people who inject drugs. Lancet 2015; 385: 115; PMID:25706466; http://dx.doi.org/10.1016/S0140-6736(15)60019-8
   PubMedGoogle Scholar
• Bekele A, Tadesse A. Status of hepatitis B vaccinationamong surgeons practicing in Ethiopia: a cross sectional study. Ethiop Med J 2014; 52:107-12; PMID:25812283
   PubMedGoogle Scholar
• Tuckerman JL, Collins JE, Marshall HS. Factors affecting uptake of recommended immunizations among health care workers in South Australia. Hum Vaccin Immunother 2015; 11:704-12; PMID:25715003; http://dx.doi.org/10.1080/21645515.2015.1008886
   PubMed Web of Science ®Google Scholar
• Ly KN, Roberts H, Williams RE, Masunu-Faleafaga Y, Drobeniuc J, Kamili S, Teshale EH. Hepatitis B vaccination for healthcare personnel in American Samoa: pre-implementation survey for policy decision. Epidemiol Infect 2014; 142:2610-5; PMID:24476680; http://dx.doi.org/10.1017/S0950268813003506
   PubMed Web of Science ®Google Scholar
• De Schryver A, Claesen B, Meheus A, van Sprundel M, François G. European survey ofhepatitis B vaccination policies for healthcare workers. Eur J Public Health 2011; 21:338-43; PMID:20817688; http://dx.doi.org/10.1093/eurpub/ckq122
   PubMed Web of Science ®Google Scholar
• Dun Z, Fu JY, Wang YZ, Dong SL, Xu RH, Chao YF. Investigation on the strategy of increasing adults' inoculation rate of hepatitis B vaccine. Mod Prev Med 2008; 35: 2135-8 [in Chinese].
   Google Scholar
• Rosenthal SL, Kottenhahn RK, Biro FM, Succop PA. Hepatitis-B vaccine acceptance among adolescents and their parents. J Adolesc Health 1995; 17: 248-54; PMID:8580126; http://dx.doi.org/10.1016/1054-139X(95)00164-N
   PubMed Web of Science ®Google Scholar
• Slonim AB, Roberto AJ, Downing CR, Adams IF, Fasano NJ, Davis-Satterla L, Miller MA. Adolescents' knowledge, beliefs, and behaviors regarding hepatitis B: Insights and implications for programs targeting vaccine-preventable diseases. J Adolesc Health 2005; 36: 178-86; PMID:15737772; http://dx.doi.org/10.1016/j.jadohealth.2004.08.002
   PubMed Web of Science ®Google Scholar
• Hou Z, Chang J, Yue D, Fang H, Meng Q, Zhang Y. Determinants of willingness to pay for self-paid vaccines in China. Vaccine 2014; 32:4471-7; PMID:24968160; http://dx.doi.org/10.1016/j.vaccine.2014.06.047
   PubMed Web of Science ®Google Scholar
• Bond L, Nolan T, Pattison P, Carlin J. Vaccine preventable diseases and immunizations: a qualitative study of mothers' perceptions of severity, susceptibility, benefits and barriers. Aust N Z J Public Health 1998; 22:441-6; PMID:9659770; http://dx.doi.org/10.1111/j.1467-842X.1998.tb01411.x
   PubMed Web of Science ®Google Scholar
• Harrington PM, Woodman C, Shannon WF. Vaccine, yes; injection, no: maternal responses to the introduction of Haemophilus influenzae type b (Hib) vaccine. Br J Gen Pract 1999; 49: 901-2; PMID:10818657
   PubMed Web of Science ®Google Scholar
• Toure A, Saadatian-Elahi M, Floret D, Lina B, Casalegno JS, Vanhems P. Knowledge and risk perception of measles and factors associated with vaccination decisions in subjects consulting university affiliated public hospitals in Lyon, France, after measles infection. Hum Vaccin Immunother 2014; 10: 1755-61; PMID:24637343; http://dx.doi.org/10.4161/hv.28486
   PubMed Web of Science ®Google Scholar